Skip Navigation

Open-Label, Multicenter, Phase I Study to Assess the Safety of P-BCMA-ALLO1 in Subjects with Relapsed / Refractory Multiple Myeloma MM

Brief Summary

Type:
Multiple Myeloma

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT04960579

Study #:
STUDY00150115

Start Date:
Jul 24, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04960579

View Complete Trial Details & Eligibility at ClinicalTrials.gov